The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.
Identifieur interne : 000268 ( Main/Exploration ); précédent : 000267; suivant : 000269The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.
Auteurs : Paul M. Anderson [France] ; Nigel C. Jones [Australie] ; Terence J. O'Brien [Australie] ; Didier Pinault [France]Source :
- Cerebral cortex (New York, N.Y. : 1991) [ 1460-2199 ] ; 2017.
Abstract
The non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) antagonist ketamine elicits a brain state resembling high-risk states for developing psychosis and early stages of schizophrenia characterized by sensory and cognitive deficits and aberrant ongoing gamma (30-80 Hz) oscillations in cortical and subcortical structures, including the thalamus. The underlying mechanisms are unknown. The goal of the present study was to determine whether a ketamine-induced psychotic-relevant state disturbs the functional state of the corticothalamic (CT) pathway. Multisite field recordings were performed in the somatosensory CT system of the sedated rat. Baseline activity was challenged by activation of vibrissa-related prethalamic inputs. The sensory-evoked thalamic response was characterized by a short-latency (∼4 ms) prethalamic-mediated negative sharp potential and a longer latency (∼10 ms) CT-mediated negative potential. Following a single subcutaneous injection of ketamine (2.5 mg/kg), spontaneously occurring and sensory-evoked thalamic gamma oscillations increased and decreased in power, respectively. The power of the sensory-related gamma oscillations was positively correlated with both the amplitude and the area under the curve of the corresponding CT potential but not with the prethalamic potential. The present results show that the layer VI CT pathway significantly contributes in thalamic gamma oscillations, and they support the hypothesis that reduced NMDAR activation disturbs the functional state of CT and corticocortical networks.
DOI: 10.1093/cercor/bhw168
PubMed: 27261525
Affiliations:
- Australie, France
- Alsace (région administrative), Grand Est, Victoria (État)
- Melbourne, Strasbourg
- Université de Melbourne
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000A86
- to stream PubMed, to step Curation: 000A83
- to stream PubMed, to step Checkpoint: 000A83
- to stream Ncbi, to step Merge: 003644
- to stream Ncbi, to step Curation: 003644
- to stream Ncbi, to step Checkpoint: 003644
- to stream Main, to step Merge: 000263
- to stream Main, to step Curation: 000268
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.</title><author><name sortKey="Anderson, Paul M" sort="Anderson, Paul M" uniqKey="Anderson P" first="Paul M" last="Anderson">Paul M. Anderson</name><affiliation wicri:level="3"><nlm:affiliation>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Jones, Nigel C" sort="Jones, Nigel C" uniqKey="Jones N" first="Nigel C" last="Jones">Nigel C. Jones</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="O Brien, Terence J" sort="O Brien, Terence J" uniqKey="O Brien T" first="Terence J" last="O'Brien">Terence J. O'Brien</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Pinault, Didier" sort="Pinault, Didier" uniqKey="Pinault D" first="Didier" last="Pinault">Didier Pinault</name><affiliation wicri:level="3"><nlm:affiliation>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27261525</idno><idno type="pmid">27261525</idno><idno type="doi">10.1093/cercor/bhw168</idno><idno type="wicri:Area/PubMed/Corpus">000A86</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A86</idno><idno type="wicri:Area/PubMed/Curation">000A83</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A83</idno><idno type="wicri:Area/PubMed/Checkpoint">000A83</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A83</idno><idno type="wicri:Area/Ncbi/Merge">003644</idno><idno type="wicri:Area/Ncbi/Curation">003644</idno><idno type="wicri:Area/Ncbi/Checkpoint">003644</idno><idno type="wicri:Area/Main/Merge">000263</idno><idno type="wicri:Area/Main/Curation">000268</idno><idno type="wicri:Area/Main/Exploration">000268</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.</title><author><name sortKey="Anderson, Paul M" sort="Anderson, Paul M" uniqKey="Anderson P" first="Paul M" last="Anderson">Paul M. Anderson</name><affiliation wicri:level="3"><nlm:affiliation>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Jones, Nigel C" sort="Jones, Nigel C" uniqKey="Jones N" first="Nigel C" last="Jones">Nigel C. Jones</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="O Brien, Terence J" sort="O Brien, Terence J" uniqKey="O Brien T" first="Terence J" last="O'Brien">Terence J. O'Brien</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Pinault, Didier" sort="Pinault, Didier" uniqKey="Pinault D" first="Didier" last="Pinault">Didier Pinault</name><affiliation wicri:level="3"><nlm:affiliation>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neuropsychologie cognitive et physiopathologie de la schizophrénie, INSERM U1114, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author></analytic><series><title level="j">Cerebral cortex (New York, N.Y. : 1991)</title><idno type="eISSN">1460-2199</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) antagonist ketamine elicits a brain state resembling high-risk states for developing psychosis and early stages of schizophrenia characterized by sensory and cognitive deficits and aberrant ongoing gamma (30-80 Hz) oscillations in cortical and subcortical structures, including the thalamus. The underlying mechanisms are unknown. The goal of the present study was to determine whether a ketamine-induced psychotic-relevant state disturbs the functional state of the corticothalamic (CT) pathway. Multisite field recordings were performed in the somatosensory CT system of the sedated rat. Baseline activity was challenged by activation of vibrissa-related prethalamic inputs. The sensory-evoked thalamic response was characterized by a short-latency (∼4 ms) prethalamic-mediated negative sharp potential and a longer latency (∼10 ms) CT-mediated negative potential. Following a single subcutaneous injection of ketamine (2.5 mg/kg), spontaneously occurring and sensory-evoked thalamic gamma oscillations increased and decreased in power, respectively. The power of the sensory-related gamma oscillations was positively correlated with both the amplitude and the area under the curve of the corresponding CT potential but not with the prethalamic potential. The present results show that the layer VI CT pathway significantly contributes in thalamic gamma oscillations, and they support the hypothesis that reduced NMDAR activation disturbs the functional state of CT and corticocortical networks.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li></country><region><li>Alsace (région administrative)</li><li>Grand Est</li><li>Victoria (État)</li></region><settlement><li>Melbourne</li><li>Strasbourg</li></settlement><orgName><li>Université de Melbourne</li></orgName></list><tree><country name="France"><region name="Grand Est"><name sortKey="Anderson, Paul M" sort="Anderson, Paul M" uniqKey="Anderson P" first="Paul M" last="Anderson">Paul M. Anderson</name></region><name sortKey="Pinault, Didier" sort="Pinault, Didier" uniqKey="Pinault D" first="Didier" last="Pinault">Didier Pinault</name></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Jones, Nigel C" sort="Jones, Nigel C" uniqKey="Jones N" first="Nigel C" last="Jones">Nigel C. Jones</name></region><name sortKey="O Brien, Terence J" sort="O Brien, Terence J" uniqKey="O Brien T" first="Terence J" last="O'Brien">Terence J. O'Brien</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000268 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000268 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27261525
|texte= The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27261525" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |